Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinhuang Qingfei Capsule versus amoxicillin-clavulanate for acute exacerbation of chronic simple bronchitis
ChiCTR2000033981Phase 4Completed
- Sponsor
- Center for Bioequivalence Studies and Clinical Research
- Start
- Oct 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Yinhuang Qingfei in chronic bronchitis (CB) (2 arms), sponsored by Center for Bioequivalence Studies and Clinical Research. Primary endpoint: Improvement of cough before and after treatment. Started Oct 2018; status: completed.
02
Drugs
Yinhuang Qingfei
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on ChiCTR2000033981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033981.